Organization
Kyoto Drug Discovery and Development
1 clinical trial
Clinical trial
A Phase 2, Double-masked, Randomized, Sham-controlled, Multiple-dose Study of the Efficacy and Safety of Intravitreal KUS121 in the Treatment of Non-Arteritic Central Retinal Artery Occlusion (CRAO)Status: Recruiting, Estimated PCD: 2024-12-01